Why can interactions last?

Examine interaction duration: MDMA and fluoxetine findings, study limitations, and a separate example involving medicines containing DXM.

Some interactions with DXM can continue after the effects a person feels have ended. Below are two studies of enzyme activity and separate prescribing rules for medicines containing DXM.

These times cannot establish a safe waiting period. Do not stop or reschedule prescribed medicines to accommodate recreational use without professional advice.

MDMA: how long did enzyme recovery take?

A controlled study involved 15 healthy men. They took MDMA by mouth, followed by DXM to test CYP2D6 activity. The abstract reports recovery after approximately 10 days [3].

In the full text, the urinary metabolic-ratio marker still differed from baseline at the 10-day observation. The authors discuss limitations of the recovery models [3]. The study did not establish an individual safe waiting interval.

Recovery half-life

A measure of how quickly enzyme activity recovers, calculated from changes in an activity marker over time.

In an exponential model, the recovery half-life is the time for a falling marker to halve. The marker can be the ratio of a test substance to its breakdown product.

Sources: Recovery half-life

In the glossary

The reported recovery half-life of 46.6 hours is a monoexponential model estimate. The authors note that the estimate appears to underestimate the time to recovery. They question the validity of a longer biphasic-model estimate because of variability in the data and insufficient data points over time [3]. See the MDMA study details.

DXM + MDMA

Fluoxetine: what persisted after stopping?

In another study, reduced CYP2D6 activity persisted for two weeks after fluoxetine was stopped. DXM was used to test enzyme activity [50].

The study measured enzyme activity; it did not determine a safe waiting period for an individual. Recovery depends on the medicine, the treatment regimen and the person.

DXM + Fluoxetine, paroxetine

How do medicines containing DXM work?

Two medicines combine DXM with a substance that increases DXM levels in the body: AUVELITY contains DXM and bupropion; NUEDEXTA contains DXM and quinidine [2, 4]. They use defined formulations and treatment regimens, with patient selection.

The same combinations can be used therapeutically under those conditions. Their existence cannot establish safety for arbitrary amounts or conditions of recreational use.

AUVELITY and NUEDEXTA rules for MAO inhibitors

MAO inhibitors (MAOIs) are medicines that inhibit monoamine oxidase. The product instructions require separation from these medicines [2, 4].

AUVELITY (DXM and bupropion):

  • After stopping an MAOI antidepressant, wait at least 14 days before starting AUVELITY.

  • After stopping AUVELITY, wait at least 14 days before starting an MAOI antidepressant.

NUEDEXTA (DXM and quinidine):

  • Contraindicated during MAOI use and within 14 days after stopping an MAOI.

  • After stopping NUEDEXTA, wait at least 14 days before starting an MAOI.

These are prescribing rules for the named products. They cannot establish a safe interval for recreational combinations.

Product instructions: AUVELITY, section 2.7 and NUEDEXTA, section 4.3.

DXM + Bupropion DXM + Quinidine

Related combinations in the atlas

Sources

Reference

Open the source and related combinations →